Document is current
Any future updates will be listed below
-
Authors
Labate, Angelo https://orcid.org/0000-0002-8827-7324
Liguori, Claudio https://orcid.org/0000-0003-2845-1332
Tartara, Elena https://orcid.org/0000-0003-1656-5420
Tumminelli, Gemma https://orcid.org/0000-0003-2098-5129
Nilo, Annacarmen https://orcid.org/0000-0001-9827-8059
Piccioli, Marta https://orcid.org/0000-0002-7953-0906
Dainese, Filippo
Del Gaudio, Luigi
Di Bonaventura, Carlo https://orcid.org/0000-0003-1890-5409
-
Funding
Funding for this research was provided by:
Angelini Pharma
- License Information
-
More Information
Article History
Received: 14 March 2025
Accepted: 28 May 2025
First Online: 30 June 2025
Declarations
:
: Claudio Liguori served as a consultant and/or received research support from Angelini. Elena Tartara and Annacarmen Nilo received speaker fees from Angelini. Filippo Dainese served as a consultant and/or received research support from Angelini. Angelo Labate, Gemma Tumminelli, Marta Piccioli, Luigi Del Gaudio, and Carlo Di Bonaventura declare no potential conflicts of interest.
: Not applicable. This work is based on published studies and expert discussion; no human or animal research was conducted.
